Pharma Biotech System Components Limited
05144311
Healthy
- 2 outstanding charges (-4)
Details
Compliance
Last accounts
31/03/2025
total exemption full
Next accounts due
31/12/2026
Confirmation statement
Last: 24/06/2026
Due 08/07/2027
Industry
Officers
secretary · Since 23/06/2011
director · Since 23/06/2011
GENERAL MANAGER
BRITISH · ENGLAND · Age 46
Also on 2 other boards
secretary · Since 23/06/2011
Former
secretary · Resigned 23/06/2011
director · Resigned 02/08/2023
director · Resigned 02/08/2023
Persons with Significant Control
Takahe Holdings Ltd
Aireside House, Royd Ings Avenue, Keighley, BD21 4BZ
Reg: 10463404 · England And Wales · Limited Company
Notified 01/04/2017
Charges2 outstanding
TAKAHE HOLDINGS LTD
CERRIG HOLDINGS LIMITED, TRUSTEE OF THE TE KAPA TRUST
NATIONAL WESTMINSTER BANK PLC
Change History
Active
Private Limited Company
PBSC - UNIT 3, MOOR PARK 25
MIRFIELD
CompanyRankvs 234+ SIC 43999 peers80
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Risk deductions
Outstanding charges: -10 pts
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/03/2026
Net Worth
£2.6M
Balance sheet strength
Cash
£944k
Cash in the bank
Net Current Assets
£2.2M
Working capital
Current Assets
£4.0M
Current Liabilities
£1.8M
Fixed Assets
£359k
Debtors
£1.9M
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2026 | 2.26 | +£316k |
| 2025 | 2.27 | +£845k |
| 2024 | 1.65 | -£190k |
| 2023 | 1.50 | — |
Derived from filed accounts. Not audited figures.